Navigation Links
Release of Universal Film The Express Draws Attention to Tragedy of Lives Cut Short by Blood Cancer
Date:10/6/2008

Rob Brown, Starring as Football Hero and Leukemia Victim Ernie Davis, Is Spokesperson for The Leukemia & Lymphoma Society's 2008 Light The Night(R)

Walk

WHITE PLAINS, N.Y., Oct. 6 /PRNewswire/ -- Ernie Davis, a 1960s football hero who was the first African-American to win the Heisman Trophy, is the subject of the new film from Universal Pictures, The Express, coming to theaters Friday, Oct. 10. Davis overcame seemingly insurmountable obstacles to become an unstoppable running back for the Syracuse University Orangemen. But his dreams of pursuing a career in the NFL as a member of the Cleveland Browns came to an abrupt end when he was tragically struck down by leukemia and died in 1963 at the age of 23.

Ernie Davis is played by Rob Brown, the spokesperson for The Leukemia & Lymphoma Society's (LLS) 2008 Light The Night Walk, a fundraising campaign that is taking place over the next few weeks in communities across the country.

"Ernie Davis's dreams were cut short by leukemia at the age of 23," says Brown. "Playing the role of Davis has helped me understand that all blood- cancer patients deserve to live better, longer lives and that supporting research to help make cures happen is critical."

"Rob Brown is an outstanding role model and a compassionate spokesperson for our cause," said Nancy Klein, LLS's chief marketing and revenue officer. "His involvement with Light The Night and The Express goes a long way toward raising awareness about the urgency of finding cures and better treatments."

To learn more or to support blood cancer research visit http://www.lls.org.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, the LLS made 6.3 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit http://www.LLS.org or call the LLS Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

Contact:

Andrea Greif

914-821-8958

andrea.greif@lls.org


'/>"/>
SOURCE Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
2. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
3. First New York/New Jersey Health Care Report Card Released
4. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
5. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
6. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
7. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
8. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
9. Verdict One Releases Directory of Board Certified Attorneys for Consumers
10. Academy releases emergency preparedness tools to enable millions more people to shelter in place
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: